medical cannabis | Prepared Foods

Items Tagged with 'medical cannabis'

ARTICLES

ALT Partners with Grow Group Plc to Launch Liquid Cannabis Products in Europe

EU GMP-certified products will be available in Europe by early 2022.

August 16, 2021

ALT uses emulsion technology to create flavor neutral, zero calorie, sugar-free, vegan, keto, and paleo friendly water-compatible medical cannabis products.

Trulieve Partners with Morehouse School of Medicine on Research, Education

Partnership represents Trulieve’s initial steps toward personalized medical cannabis treatment.

March 15, 2021

No Comments

Trulieve and the Morehouse School of Medicine have entered into a collaborative research, education and development agreement where Trulieve Georgia will support Morehouse School of Medicine medical cannabis-related research and development projects.

Q&A with Dr. Jeff Chen, founder of UCLA Cannabis Research Initiative

Cannabis Products Exchange set to be held virtually April 27-28.

Alyse Thompson

March 9, 2021

No Comments

Chen will present “Formulating Cannabis-Infused F&B Products For The Medical And Functional Foods Market” during Cannabis Products Exchange, slated to be held virtually April 27-28.

Trulieve to Introduce Edibles into Florida Medical Cannabis Market

Company built 10,000 sq. ft. commercial kitchen at production facility in Quincy, FL.

August 27, 2020

No Comments

Following finalized regulations from the Florida Department of Health for the sale of edible cannabis products, Trulieve will introduce edibles in its medical cannabis dispensaries across the state.

FDA Approves Epidiolex Oral Solution to Treat Seizures Associated with Rare Genetic Disease

Double-blind study showed Epidiolex reduced seizure frequency in tuberous sclerosis complex patients.

August 3, 2020

No Comments

The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.

CANNABIS PRODUCTS | AUGUST 2020

Advancing Medical Cannabis Opportunities

Researchers continue to work toward a better understanding of how cannabinoids can benefit human health.

Douglas J. Peckenpaugh

August 3, 2020

No Comments

Today, medical cannabis is approved for use in 33 U.S. states plus the District of Columbia, and several other states have medical or recreational cannabis legalization on the fall election ballot.

CANNABIS PRODUCTS | JUNE 2020

Medical Cannabis-Infused Food and Beverage Market Poised for Growth

Legal cannabis sales grew by 46 percent to $14.8 billion in 2019, BDSA reports.

Douglas J. Peckenpaugh

June 16, 2020

No Comments

For many consumers dealing with a variety of medical conditions, cannabis is essential medicine. And the market for cannabis-infused foods and beverages shows significant potential for growth.

Massachusetts Cannabis Sales Projected to Surpass $1B in 2024

BDS Analytics launches retail sales tracking in Massachusetts.

April 13, 2020

No Comments

BDS Analytics has launched adult-use and medical cannabis retail sales tracking in Massachusetts.

CANNABIS PRODUCTS | JUNE 2020

Coda Signature Expands Medical Portfolio with New Chocolate Bars

Chocolate bars contain 500-1,000mg THC for medical cannabis patients.

April 6, 2020

No Comments

Coda Signature has released infused chocolate bars with expanded dosage options for medical patients.

CANNABIS PRODUCTS | NOVEMBER 2019

Cannabis Edibles and Beverages Industry Growth

A look at leading performance indicators across the industry points clear directions toward a profitable future.

Douglas J. Peckenpaugh

November 4, 2019

No Comments

The legal cannabis market is the hottest industry in the U.S. By 2023, Brightfield Group estimates that the total U.S. market will reach $22.7 billion, with a CAGR of 20 percent from 2019 to 2023.

More Articles Tagged with 'medical cannabis'

The immune and gut health space is packed with pre and pro-biotic products, making it hard to stand out, but now there’s a new player in the game: postbiotics.